Artigo
Revisado por pares
O-104 XYOTAXT™ vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The STELLAR 4 Phase III study
2005; Elsevier BV; Volume: 49; Linguagem: Inglês
10.1016/s0169-5002(05)80238-7
ISSN1872-8332
AutoresM. O’Brien, Alan Sandler, Alexander Y. Popovich, Hristo Ganchev, Natalia Bogdanova, José Elias Miziara,
Tópico(s)Lung Cancer Research Studies
Referência(s)